Baseline Response Criterion and Changes in Emotional Bias as Markers of Esketamine Response in Treatment-Resistant Depression

This study (n=53) compared emotional face processing in people with treatment-resistant depression and healthy controls before and during 4 weeks of esketamine treatment. A lower baseline response criterion was associated with better subsequent improvement, while reduced negative interpretation of neutral faces tracked treatment response, suggesting these measures may help identify and monitor responders.